Jen Barnes

611 total citations
15 papers, 501 citations indexed

About

Jen Barnes is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Jen Barnes has authored 15 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Jen Barnes's work include Neuroscience and Neuropharmacology Research (4 papers), Neuropeptides and Animal Physiology (4 papers) and Receptor Mechanisms and Signaling (3 papers). Jen Barnes is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Neuropeptides and Animal Physiology (4 papers) and Receptor Mechanisms and Signaling (3 papers). Jen Barnes collaborates with scholars based in United Kingdom, Canada and United States. Jen Barnes's co-authors include Guy A. Higgins, Deborah Evans, D. I. C. SCOPES, H. Thomas Rupniak, Richard B. Anderson, J. W. CLITHEROW, A.D. Michel, Jason Brown, Ann G. Hayes and Jane Clapham and has published in prestigious journals such as Cancer Research, Brain Research and Neuroscience.

In The Last Decade

Jen Barnes

14 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jen Barnes United Kingdom	11	218	170	161	73	67	15	501
Sylvain J. Robert France	6	244 1.1×	134 0.8×	174 1.1×	41 0.6×	39 0.6×	6	449
Donna L. Maier United States	13	276 1.3×	257 1.5×	295 1.8×	40 0.5×	116 1.7×	21	725
Pavel I. Zimin United States	8	255 1.2×	195 1.1×	170 1.1×	23 0.3×	25 0.4×	10	560
Anna Traficante Italy	13	271 1.2×	159 0.9×	345 2.1×	20 0.3×	43 0.6×	15	723
Sandra Colié France	10	262 1.2×	165 1.0×	88 0.5×	36 0.5×	28 0.4×	12	495
Ulrich H. Schröder Germany	15	508 2.3×	299 1.8×	555 3.4×	40 0.5×	110 1.6×	26	935
Anne M. Morin United States	13	226 1.0×	135 0.8×	256 1.6×	23 0.3×	55 0.8×	20	516
F. Imbault France	6	345 1.6×	78 0.5×	529 3.3×	75 1.0×	83 1.2×	8	805
Tomonari Watabiki Japan	13	294 1.3×	294 1.7×	226 1.4×	22 0.3×	17 0.3×	14	605
A. Flamier France	7	352 1.6×	76 0.4×	396 2.5×	62 0.8×	47 0.7×	8	630

Countries citing papers authored by Jen Barnes

Since Specialization

Citations

This map shows the geographic impact of Jen Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen Barnes more than expected).

Fields of papers citing papers by Jen Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen Barnes. The network helps show where Jen Barnes may publish in the future.

Co-authorship network of co-authors of Jen Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Jen Barnes. A scholar is included among the top collaborators of Jen Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen Barnes. Jen Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

O’Connor, Lenka Oplustil, Anderson T. Wang, D. I. Jones, et al.. (2017). Abstract B32: CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, combined with DDR agents provides a novel approach to increasing therapeutic index. Molecular Cancer Research. 15(4_Supplement). B32–B32.

Shankaran, Harish, Anna Cronin, Jen Barnes, et al.. (2017). Systems Pharmacology Model of Gastrointestinal Damage Predicts Species Differences and Optimizes Clinical Dosing Schedules. CPT Pharmacometrics & Systems Pharmacology. 7(1). 26–33. 14 indexed citations

Guichard, Sylvie M., Rajesh Odedra, Adina Hughes, et al.. (2013). Abstract 3343: The pre-clinical in vitro and in vivo activity of AZD6738: A potent and selective inhibitor of ATR kinase.. Cancer Research. 73(8_Supplement). 3343–3343. 18 indexed citations

Jacq, Xavier, Lisa M. Smith, Adina Hughes, et al.. (2012). Abstract 1823: AZ20, a novel potent and selective inhibitor of ATR kinase with in vivo antitumour activity. Cancer Research. 72(8_Supplement). 1823–1823. 10 indexed citations

Richardson, Jill, Richard B. Anderson, Elaine Gower, et al.. (2003). Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease. Neuroscience. 122(1). 213–228. 72 indexed citations

Barnes, Jen, et al.. (2000). Oxidative signalling and inflammatory pathways in Alzheimer's disease. Biochemical Society Transactions. 28(1). A17–A17. 2 indexed citations

Anderson, Richard B., Jen Barnes, T.V.P. Bliss, et al.. (1998). Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience. 85(1). 93–110. 98 indexed citations

Evans, Deborah, et al.. (1997). Evidence for recovery of spatial learning following entorhinal cortex lesions in mice. Brain Research. 758(1-2). 187–200. 52 indexed citations

Barnes, Jen, et al.. (1996). Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.. PubMed. 7(6). 513–525. 46 indexed citations

10.

CLITHEROW, J. W., Paul Beswick, D. I. C. SCOPES, et al.. (1996). Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 6(7). 833–838. 88 indexed citations

11.

Connell, Barry J., et al.. (1994). Rapid development of tolerance to morphine in the formalin test. Neuroreport. 5(7). 817–820. 11 indexed citations

12.

Hawcock, A.B. & Jen Barnes. (1993). Pharmacological characterization of the contractile responses to angiotensin analogues in guinea‐pig isolated longitudinal muscle of small intestine. British Journal of Pharmacology. 108(4). 1150–1155. 8 indexed citations

13.

Robertson, Mark J., Jen Barnes, G.M. Drew, et al.. (1992). Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist. British Journal of Pharmacology. 107(4). 1173–1180. 66 indexed citations

14.

Hawcock, A.B., Jen Barnes, & A.D. Michel. (1992). Pharmacological characterization of angiotensin‐induced depolarizations of rat superior cervical ganglion in vitro. British Journal of Pharmacology. 105(3). 686–690. 11 indexed citations

15.

Barnes, Jen, Nicky Barnes, Nicholas M. Barnes, et al.. (1987). Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: Behavioural correlates in rodent and primate. Neuropharmacology. 26(7). 693–700. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact